Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

US Patent 12018057 · Granted Jun 25, 2024

Estimated economic value: $184,084,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Hepcidin analogues and uses thereof2025
Conjugated hepcidin mimetics2025
Conjugated hepcidin mimetics2025
PCSK9 antagonist compounds2025
PCSK9 antagonist compounds2025
Immunoglobulins and uses thereof2024
Cyclic polypeptides for PCSK9 inhibition2024